ENG
Topical Drug Delivery Market: Global Industry Analysis and Forecast (2024-2030) by Product, Route of Administration, Facility of Use, and Region
Topical Drug Delivery Market size was valued at US$ 115.31 Bn. in 2023 and the total revenue is expected to grow at a CAGR of 6.6% through 2024 to 2030, reaching nearly US$ 180.38 Bn
Format : PDF | Report ID : SMR_358
Topical Drug Delivery Market Overview:
A topical drug delivery system (TDDS) is a method of delivering medications to the skin for topical therapeutic effects. Pharmacists use the skin to deliver various medications because it is one of the largest and most superficial organs in the human body. This system usually has a local influence on specific body postures.
Though topical drug delivery market forecast through 2027 is based on real output, demand and supply of 2020, 2020 numbers are also estimated on real numbers published by key players as well all-important players across the world. Market forecasting till 2027 is done based on past data from 2016 to 2019 with the impact of global lock down on the market in 2020 and 2021.
To get more Insights: Request Free Sample Report
Topical Drug Delivery Market Dynamics:
Skin diseases such as psoriasis, eczema, skin cancer, and vitiligo continue to be the fourth-leading cause of nonfatal disease burden globally, according to the Global Burden of Disease Project, and affect a considerable proportion of the global population. According to the World Health Organization, between 2 and 3 million cases of non-melanoma skin cancer and 132,000 cases of melanoma skin cancer are detected each year. Furthermore, the global prevalence of psoriasis ranges from 0.09 percent to 11.43 percent, making it a severe global disease affecting at least 100 million people. The Topical Drug Delivery Market is expected to grow, due to rise in demand for sophisticated topical products, as topical drug administration is the first line of treatment for the majority of skin illnesses.
Patients and end users can choose from a variety of medicine delivery options. The advantages of these options over topical drug delivery are a significant impediment to the topical drug delivery market's growth. The oral route is the most popular since it is simple to use, convenient, cost-effective, and safe. Orally delivered medications can also be kept easily and are portable, cost-effective, noninvasive, and safe. In comparison to topical preparations, no additional training is necessary for the administration of these medications. Injectables, such as insulin injections for diabetics to self-administer, are also widely used.
One of the emerging trends in the topical drug delivery market is the delivery of biologics via the transdermal route. The use of transdermal delivery of big molecules instead of intramuscular, subcutaneous, or intravenous routes of administration is expected to give considerable patient benefits, including painless medication delivery and cost-effective treatment.
Topical Drug Delivery Market Segment Analysis:
Based on the Product, the market is segmented into Semi-solid Formulations, Liquid Formulations, Solid Formulations, and Transdermal Products. Semi-solid Formulations segment is expected to hold the largest market shares of xx% by 2030. The factors are due to their capacity to deliver a wide range of pharmacological molecules and the ease with which semi-solid formulations can be applied. Creams, gels, ointments, suppositories, and other topical dose forms fall into the semi-solid medication group. Consistency, dosage homogeneity, preservatives, method of administration, and formulation base are all characteristics shared by semi-solid medication formulations. These are the factors that are expected to drives the growth of this segment in the Topical Drug Delivery market during the forecast period 2024-2030.
Based on the Route of Administration, the market is segmented into Dermal Drug Delivery, Ophthalmic Drug Delivery, Rectal Drug Delivery, Vaginal Drug Delivery, and Nasal Drug Delivery. Dermal Drug Delivery segment is expected to grow rapidly at a CAGR of xx% during the forecast period 2024-2030. Because it is more convenient and patient-friendly than other topical medication delivery methods. Dermal products are subject to less regulations than ophthalmic products, which must undergo sterility testing.
Based on the Facility of Use, the topical drug delivery market is segmented into Home Care Settings, Hospitals & Clinics, Burn Centers, and Other Facilities. Home Care Settings segment is expected to grow rapidly at a CAGR of xx% during the forecast period 2024-2030. This is due to major factors such as the ease of use and low cost of topical medicines for home administration. Furthermore, for patients who require long-term therapy, inpatient care is not only prohibitive to resuming a normal lifestyle and work activities, but it is also prohibitively expensive. In this aspect, technological improvements have aided patients in receiving therapies at home in an effective and safe manner.
Topical Drug Delivery Market Regional Insights:
North America region is expected to dominate the Topical Drug Delivery market during the forecast period 2024-2030. North America region is expected to hold the largest market share of xx% by 2030. The market is expecting positive growth as a result of the COVID-19 outbreak. This is primarily owing to the unique treatment that is currently being developed. For example, the US Food and Drug Administration authorised 'T3X,' an over-the-counter ointment created by Advanced Penetration Technology, in August 2020. It has been found to be effective against the SARS-CoV-2 virus. Due to circumstances such as the availability of a wide number of pharmaceutical businesses and medication delivery technology suppliers, research have revealed that T3X was able to eliminate the virus within 30 seconds. These are the key major drivers that are expected to drives the growth of the North America region in the Topical Drug Delivery Market during the forecast period.
Asia Pacific region is expected to grow rapidly at a CAGR of xx% during the forecast period 2024-2030. Topical drug delivery has been on the rise in Asia Pacific, as a result of skin diseases (e.g. skin cancer), increasing contraceptive use, and the focus of pharmaceutical companies on developing smart transdermal drug delivery systems.
The objective of the report is to present a comprehensive analysis of the Topical Drug Delivery Market to the stakeholders in the industry. The report provides trends that are most dominant in the Topical Drug Delivery Market and how these trends will influence new business investments and market development throughout the forecast period. The report also aids in the comprehension of the market dynamics and competitive structure of the market by analyzing market leaders, market followers, and regional players.
The qualitative and quantitative data provided in the Topical Drug Delivery Market report is to help understand which market segments, regions are expected to grow at higher rates, factors affecting the market, and key opportunity areas, which will drive the industry and market growth through the forecast period. The report also includes the competitive landscape of key players in the industry along with their recent developments in the Topical Drug Delivery Market. The report studies factors such as company size, market share, market growth, revenue, production volume, and profits of the key players in the global market.
The report provides Porter's Five Force Model, which helps in designing the business strategies in the market. The report helps in identifying how many rivals are existing, who they are, and how their product quality is in the Market. The report also analyses if the Topical Drug Delivery Market is easy for a new player to gain a foothold in the market, do they enter or exit the market regularly if the market is dominated by a few players, etc.
The report also includes a PESTEL Analysis, which aids in the development of company strategies. Political variables help in figuring out how much a government can influence the Market. Economic variables aid in the analysis of economic performance drivers that have an impact on the Market. Understanding the impact of the surrounding environment and the influence of environmental concerns on the Topical Drug Delivery Market is aided by legal factors.
Topical Drug Delivery Market Scope:
|
Topical Drug Delivery Market |
|
|
Market Size in 2023 |
USD 115.31 Bn. |
|
Market Size in 2030 |
USD 180.38 Bn. |
|
CAGR (2024-2030) |
6.6% |
|
Historic Data |
2018-2022 |
|
Base Year |
2023 |
|
Forecast Period |
2024-2030 |
|
Segment Scope |
By Product
|
|
By Route of Administration
|
|
|
By Facility of Use
|
|
|
Regional Scope |
North America- United States, Canada, and Mexico Europe – UK, France, Germany, Italy, Spain, Sweden, Austria, and Rest of Europe Asia Pacific – China, India, Japan, South Korea, Australia, ASEAN, Rest of APAC Middle East and Africa - South Africa, GCC, Egypt, Nigeria, Rest of the Middle East and Africa South America – Brazil, Argentina, Rest of South America |
Topical Drug Delivery Market Key Players
- Johnson & Johnson (US)
- Nestlé SA (Switzerland)
- Novartis AG (Switzerland)
- GlaxoSmithKline (UK)
- Bausch Health Companies (Canada)
- Merck & Co (US)
- Bayer AG (Germany)
- Hisamitsu Pharmaceutical (Japan)
- Glenmark Pharmaceuticals (India)
- Cipla Ltd (India)
- Crescita Therapeutics Inc. (Canada)
- Mylan (US)
- Encore Dermatology, Inc. (US)
- LEO Pharma (Denmark)
- Almirall, S.A (Spain)
- Aclaris Therapeutics, Inc. (US)
- Taro Pharmaceutical Industries Ltd. (US)
Frequently Asked Questions
North America is expected to hold the highest share in the Topical Drug Delivery Market.
Johnson & Johnson (US), Nestlé SA (Switzerland), Novartis AG (Switzerland), GlaxoSmithKline (UK), and Bausch Health Companies (Canada) are the top key players in the Topical Drug Delivery Market.
Semi-solid Formulations segment hold the largest market share in the Topical Drug Delivery market by 2030.
The market size of the Topical Drug Delivery market is expected to reach US $ 180.38 Bn. by 2030.
The market size of the Topical Drug Delivery market was worth US $ 115.31 Bn. in 2023.
Chapter 1 Scope of the Report
Chapter 2 Research Methodology
2.1. Research Process
2.2. Global Topical Drug Delivery Market: Target Audience
2.3. Global Topical Drug Delivery Market: Primary Research (As per Client Requirement)
2.4. Global Topical Drug Delivery Market: Secondary Research
Chapter 3 Executive Summary
Chapter 4 Competitive Landscape
4.1. Market Share Analysis, By Value, 2023-2030
4.1.1. Market Share Analysis, By Region, By Value, 2023-2030 (In %)
4.1.1.1. North America Market Share Analysis, By Value, 2023-2030 (In %)
4.1.1.2. Europe Market Share Analysis, By Value, 2023-2030 (In %)
4.1.1.3. Asia Pacific Market Share Analysis, By Value, 2023-2030 (In %)
4.1.1.4. South America Market Share Analysis, By Value, 2023-2030 (In %)
4.1.1.5. Middle East and Africa Market Share Analysis, By Value, 2023-2030 (In %)
4.1.2. Market Share Analysis, By Product, By Value, 2023-2030 (In %)
4.1.2.1. North America Market Share Analysis, By Product, By Value, 2023-2030 (In %)
4.1.2.1.1. USA Market Share Analysis, By Product, By Value, 2023-2030 (In %)
4.1.2.1.2. Canada Market Share Analysis, By Product, By Value, 2023-2030 (In %)
4.1.2.1.3. Mexico Market Share Analysis, By Product, By Value, 2023-2030 (In %)
4.1.2.2. Europe Market Share Analysis, By Product, By Value, 2023-2030 (In %)
4.1.2.2.1. UK Market Share Analysis, By Product, By Value, 2023-2030 (In %)
4.1.2.2.2. France Market Share Analysis, By Product, By Value, 2023-2030 (In %)
4.1.2.2.3. Germany Market Share Analysis, By Product, By Value, 2023-2030 (In %)
4.1.2.2.4. Italy Market Share Analysis, By Product, By Value, 2023-2030 (In %)
4.1.2.2.5. Spain Market Share Analysis, By Product, By Value, 2023-2030 (In %)
4.1.2.2.6. Sweden Market Share Analysis, By Product, By Value, 2023-2030 (In %)
4.1.2.2.7. Austria Market Share Analysis, By Product, By Value, 2023-2030 (In %)
4.1.2.2.8. Rest of Europe Market Share Analysis, By Product, By Value, 2023-2030 (In %)
4.1.2.3. Asia Pacific Market Share Analysis, By Product, By Value, 2023-2030 (In %)
4.1.2.3.1. China Market Share Analysis, By Product, By Value, 2023-2030 (In %)
4.1.2.3.2. India Market Share Analysis, By Product, By Value, 2023-2030 (In %)
4.1.2.3.3. Japan Market Share Analysis, By Product, By Value, 2023-2030 (In %)
4.1.2.3.4. South Korea Market Share Analysis, By Product, By Value, 2023-2030 (In %)
4.1.2.3.5. Australia Market Share Analysis, By Product, By Value, 2023-2030 (In %)
4.1.2.3.6. ASEAN Market Share Analysis, By Product, By Value, 2023-2030 (In %)
4.1.2.3.7. Rest of APAC Market Share Analysis, By Product, By Value, 2023-2030 (In %)
4.1.2.4. South America Market Share Analysis, By Product, By Value, 2023-2030 (In %)
4.1.2.4.1. Brazil Market Share Analysis, By Product, By Value, 2023-2030 (In %)
4.1.2.4.2. Argentina Market Share Analysis, By Product, By Value, 2023-2030 (In %)
4.1.2.4.3. Rest of South America Market Share Analysis, By Product, By Value, 2023-2030 (In %)
4.1.2.5. Middle East and Africa Market Share Analysis, By Product, By Value, 2023-2030 (In %)
4.1.2.5.1. South Africa Market Share Analysis, By Product, By Value, 2023-2030 (In %)
4.1.2.5.2. GCC Market Share Analysis, By Product, By Value, 2023-2030 (In %)
4.1.2.5.3. Egypt Market Share Analysis, By Product, By Value, 2023-2030 (In %)
4.1.2.5.4. Nigeria Market Share Analysis, By Product, By Value, 2023-2030 (In %)
4.1.2.5.5. Rest of Middle East and Africa Market Share Analysis, By Product, By Value, 2023-2030 (In %)
4.1.3. Market Share Analysis, By Route of Administration, By Value, 2023-2030 (In %)
4.1.3.1. North America Market Share Analysis, By Route of Administration, By Value, 2023-2030 (In %)
4.1.3.1.1. USA Market Share Analysis, By Route of Administration, By Value, 2023-2030 (In %)
4.1.3.1.2. Canada Market Share Analysis, By Route of Administration, By Value, 2023-2030 (In %)
4.1.3.1.3. Mexico Market Share Analysis, By Route of Administration, By Value, 2023-2030 (In %)
4.1.3.2. Europe Market Share Analysis, By Route of Administration, By Value, 2023-2030 (In %)
4.1.3.2.1. UK Market Share Analysis, By Route of Administration, By Value, 2023-2030 (In %)
4.1.3.2.2. France Market Share Analysis, By Route of Administration, By Value, 2023-2030 (In %)
4.1.3.2.3. Germany Market Share Analysis, By Route of Administration, By Value, 2023-2030 (In %)
4.1.3.2.4. Italy Market Share Analysis, By Route of Administration, By Value, 2023-2030 (In %)
4.1.3.2.5. Spain Market Share Analysis, By Route of Administration, By Value, 2023-2030 (In %)
4.1.3.2.6. Sweden Market Share Analysis, By Route of Administration, By Value, 2023-2030 (In %)
4.1.3.2.7. Austria Market Share Analysis, By Route of Administration, By Value, 2023-2030 (In %)
4.1.3.2.8. Rest of Europe Market Share Analysis, By Route of Administration, By Value, 2023-2030 (In %)
4.1.3.3. Asia Pacific Market Share Analysis, By Route of Administration, By Value, 2023-2030 (In %)
4.1.3.3.1. China Market Share Analysis, By Route of Administration, By Value, 2023-2030 (In %)
4.1.3.3.2. India Market Share Analysis, By Route of Administration, By Value, 2023-2030 (In %)
4.1.3.3.3. Japan Market Share Analysis, By Route of Administration, By Value, 2023-2030 (In %)
4.1.3.3.4. South Korea Market Share Analysis, By Route of Administration, By Value, 2023-2030 (In %)
4.1.3.3.5. Australia Market Share Analysis, By Route of Administration, By Value, 2023-2030 (In %)
4.1.3.3.6. ASEAN Market Share Analysis, By Route of Administration, By Value, 2023-2030 (In %)
4.1.3.3.7. Rest of APAC Market Share Analysis, By Route of Administration, By Value, 2023-2030 (In %)
4.1.3.4. South America Market Share Analysis, By Route of Administration, By Value, 2023-2030 (In %)
4.1.3.4.1. Brazil Market Share Analysis, By Route of Administration, By Value, 2023-2030 (In %)
4.1.3.4.2. Argentina Market Share Analysis, By Route of Administration, By Value, 2023-2030 (In %)
4.1.3.4.3. Rest of South America Market Share Analysis, By Route of Administration, By Value, 2023-2030 (In %)
4.1.3.5. Middle East and Africa Market Share Analysis, By Route of Administration, By Value, 2023-2030 (In %)
4.1.3.5.1. South Africa Market Share Analysis, By Route of Administration, By Value, 2023-2030 (In %)
4.1.3.5.2. GCC Market Share Analysis, By Route of Administration, By Value, 2023-2030 (In %)
4.1.3.5.3. Egypt Market Share Analysis, By Route of Administration, By Value, 2023-2030 (In %)
4.1.3.5.4. Nigeria Market Share Analysis, By Route of Administration, By Value, 2023-2030 (In %)
4.1.3.5.5. Rest of Middle East and Africa Market Share Analysis, By Route of Administration, By Value, 2023-2030 (In %)
4.1.4. Market Share Analysis, By Facility of Use, By Value, 2023-2030 (In %)
4.1.4.1. North America Market Share Analysis, By Facility of Use, By Value, 2023-2030 (In %)
4.1.4.1.1. USA Market Share Analysis, By Facility of Use, By Value, 2023-2030 (In %)
4.1.4.1.2. Canada Market Share Analysis, By Facility of Use, By Value, 2023-2030 (In %)
4.1.4.1.3. Mexico Market Share Analysis, By Facility of Use, By Value, 2023-2030 (In %)
4.1.4.2. Europe Market Share Analysis, By Facility of Use, By Value, 2023-2030 (In %)
4.1.4.2.1. UK Market Share Analysis, By Facility of Use, By Value, 2023-2030 (In %)
4.1.4.2.2. France Market Share Analysis, By Facility of Use, By Value, 2023-2030 (In %)
4.1.4.2.3. Germany Market Share Analysis, By Facility of Use, By Value, 2023-2030 (In %)
4.1.4.2.4. Italy Market Share Analysis, By Facility of Use, By Value, 2023-2030 (In %)
4.1.4.2.5. Spain Market Share Analysis, By Facility of Use, By Value, 2023-2030 (In %)
4.1.4.2.6. Sweden Market Share Analysis, By Facility of Use, By Value, 2023-2030 (In %)
4.1.4.2.7. Austria Market Share Analysis, By Facility of Use, By Value, 2023-2030 (In %)
4.1.4.2.8. Rest of Europe Market Share Analysis, By Facility of Use, By Value, 2023-2030 (In %)
4.1.4.3. Asia Pacific Market Share Analysis, By Facility of Use, By Value, 2023-2030 (In %)
4.1.4.3.1. China Market Share Analysis, By Facility of Use, By Value, 2023-2030 (In %)
4.1.4.3.2. India Market Share Analysis, By Facility of Use, By Value, 2023-2030 (In %)
4.1.4.3.3. Japan Market Share Analysis, By Facility of Use, By Value, 2023-2030 (In %)
4.1.4.3.4. South Korea Market Share Analysis, By Facility of Use, By Value, 2023-2030 (In %)
4.1.4.3.5. Australia Market Share Analysis, By Facility of Use, By Value, 2023-2030 (In %)
4.1.4.3.6. ASEAN Market Share Analysis, By Facility of Use, By Value, 2023-2030 (In %)
4.1.4.3.7. Rest of APAC Market Share Analysis, By Facility of Use, By Value, 2023-2030 (In %)
4.1.4.4. South America Market Share Analysis, By Facility of Use, By Value, 2023-2030 (In %)
4.1.4.4.1. Brazil Market Share Analysis, By Facility of Use, By Value, 2023-2030 (In %)
4.1.4.4.2. Argentina Market Share Analysis, By Facility of Use, By Value, 2023-2030 (In %)
4.1.4.4.3. Rest of South America Market Share Analysis, By Facility of Use, By Value, 2023-2030 (In %)
4.1.4.5. Middle East and Africa Market Share Analysis, By Facility of Use, By Value, 2023-2030 (In %)
4.1.4.5.1. South Africa Market Share Analysis, By Facility of Use, By Value, 2023-2030 (In %)
4.1.4.5.2. GCC Market Share Analysis, By Facility of Use, By Value, 2023-2030 (In %)
4.1.4.5.3. Egypt Market Share Analysis, By Facility of Use, By Value, 2023-2030 (In %)
4.1.4.5.4. Nigeria Market Share Analysis, By Facility of Use, By Value, 2023-2030 (In %)
4.1.4.5.5. Rest of Middle East and Africa Market Share Analysis, By Facility of Use, By Value, 2023-2030 (In %)
4.2. Stellar Competition matrix
4.2.1. Global Stellar Competition Matrix
4.2.2. North America Stellar Competition Matrix
4.2.3. Europe Stellar Competition Matrix
4.2.4. Asia Pacific Stellar Competition Matrix
4.2.5. South America Stellar Competition Matrix
4.2.6. Middle East and Africa Stellar Competition Matrix
4.3. Key Players Benchmarking
4.3.1. Key Players Benchmarking By Product, Pricing, Market Share, Investments, Expansion Plans, Physical Presence and Presence in the Market.
4.4. Mergers and Acquisitions in Industry
4.4.1. M&A by Region, Value and Strategic Intent
4.5. Market Dynamics
4.5.1. Market Drivers
4.5.2. Market Restraints
4.5.3. Market Opportunities
4.5.4 Market Challenges
4.5.5. PESTLE Analysis
4.5.6. PORTERS Five Force Analysis
4.5.7. Value Chain Analysis
Chapter 5 Global Topical Drug Delivery Market Segmentation: By Product
5.1. Global Topical Drug Delivery Market, By Product, Overview/Analysis, 2023-2030
5.2. Global Topical Drug Delivery Market, By Product, By Value, Market Share (%), 2023-2030 (USD Million)
5.3. Global Topical Drug Delivery Market, By Product, By Value, -
5.3.1. Semi-Solid Formulations
5.3.2. Liquid Formulations
5.3.3. Solid Formulations
5.3.4. Transdermal Products
Chapter 6 Global Topical Drug Delivery Market Segmentation: By Route of Administration
6.1. Global Topical Drug Delivery Market, By Route of Administration, Overview/Analysis, 2023-2030
6.2. Global Topical Drug Delivery Market Size, By Route of Administration, By Value, Market Share (%), 2023-2030 (USD Million)
6.3. Global Topical Drug Delivery Market, By Route of Administration, By Value, -
6.3.1. Dermal Drug Delivery
6.3.2. Ophthalmic Drug Delivery
6.3.3. Rectal Drug Delivery
6.3.4. Vaginal Drug Delivery
6.3.5. Nasal Drug Delivery
Chapter 7 Global Topical Drug Delivery Market Segmentation: By Facility of Use
7.1. Global Topical Drug Delivery Market, By Facility of Use, Overview/Analysis, 2023-2030
7.2. Global Topical Drug Delivery Market Size, By Facility of Use, By Value, Market Share (%), 2023-2030 (USD Million)
7.3. Global Topical Drug Delivery Market, By Facility of Use, By Value, -
7.3.1. Home Care Settings
7.3.2. Hospitals & Clinics
7.3.3. Burn Centers
7.3.4. Other Facilities
Chapter 8 Global Topical Drug Delivery Market Segmentation: By Region
8.1. Global Topical Drug Delivery Market, By Region – North America
8.1.1. North America Topical Drug Delivery Market Size, By Product, By Value, 2023-2030 (USD Million)
8.1.2. North America Topical Drug Delivery Market Size, By Route of Administration, By Value, 2023-2030 (USD Million)
8.1.3. North America Topical Drug Delivery Market Size, By Facility of Use, By Value, 2023-2030 (USD Million)
8.1.4. By Country – U.S.
8.1.4.1. U.S. Topical Drug Delivery Market Size, By Product, By Value, 2023-2030 (USD Million)
8.1.4.2. U.S. Topical Drug Delivery Market Size, By Route of Administration, By Value, 2023-2030 (USD Million)
8.1.4.3. U.S. Topical Drug Delivery Market Size, By Facility of Use, By Value, 2023-2030 (USD Million)
8.1.4.4. Canada Topical Drug Delivery Market Size, By Value, 2023-2030 (USD Million)
8.1.4.5. Mexico Topical Drug Delivery Market Size, By Value, 2023-2030 (USD Million)
8.2. Europe Topical Drug Delivery Market Size, By Value, 2023-2030 (USD Million)
8.2.1. UK
8.2.2. France
8.2.3. Germany
8.2.4. Italy
8.2.5. Spain
8.2.6. Sweden
8.2.7. Austria
8.2.8. Rest of Europe
8.3. Asia Pacific Topical Drug Delivery Market Size, By Value, 2023-2030 (USD Million)
8.3.1. China
8.3.2. India
8.3.3. Japan
8.3.4. South Korea
8.3.5. Australia
8.3.6. ASEAN
8.3.7.Rest of APAC
8.4. Middle East and Africa Topical Drug Delivery Market Size, By Value, 2023-2030 (USD Million)
8.4.1. South Africa
8.4.2. GCC
8.4.3. Egypt
8.4.4. Nigeria
8.4.5. Rest of Middle East and Africa
8.5. South America Topical Drug Delivery Market Size, By Value, 2023-2030 (USD Million)
8.5.1. Brazil
8.5.2. Argentina
8.5.3. Rest of South America
Chapter 9 Company Profiles
9.1. Key Players
9.1.1. Johnson & Johnson (US)
9.1.1.1. Company Overview
9.1.1.2. Tube Portfolio
9.1.1.3. Financial Overview
9.1.1.4. Business Strategy
9.1.1.5. Key Developments
9.1.2. Nestlé SA (Switzerland)
9.1.3. Novartis AG (Switzerland)
9.1.4. GlaxoSmithKline (UK)
9.1.5. Bausch Health Companies (Canada)
9.1.6. Merck & Co (US)
9.1.7.Bayer AG (Germany)
9.1.8. Hisamitsu Pharmaceutical (Japan)
9.1.9. Glenmark Pharmaceuticals (India)
9.1.10.Cipla Ltd (India)
9.1.11.Crescita Therapeutics Inc. (Canada)
9.1.12.Mylan (US)
9.1.13.Encore Dermatology, Inc. (US)
9.1.14.LEO Pharma (Denmark)
9.1.15.Almirall, S.A (Spain)
9.1.16.Aclaris Therapeutics, Inc. (US)
9.1.17.Taro Pharmaceutical Industries Ltd. (US)
9.2. Key Findings
9.3. Recommendations
